0000908662-20-000031.txt : 20200211 0000908662-20-000031.hdr.sgml : 20200211 20200211160225 ACCESSION NUMBER: 0000908662-20-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200207 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CGI Cellerate RX, LLC CENTRAL INDEX KEY: 0001766396 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 20596496 BUSINESS ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 BUSINESS PHONE: 512-320-8600 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Catalyst Rochal, LLC CENTRAL INDEX KEY: 0001766398 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 20596497 BUSINESS ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 BUSINESS PHONE: 512-320-8600 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gurasich Bradley J. CENTRAL INDEX KEY: 0001766399 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 20596498 MAIL ADDRESS: STREET 1: C/O THE CATALYST GROUP, INC. STREET 2: 7500 RIALTO BLVD., BLDG. II, SUITE 220 CITY: AUSTIN STATE: TX ZIP: 78735 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sanara MedTech Inc. CENTRAL INDEX KEY: 0000714256 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 592220004 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-529-2300 MAIL ADDRESS: STREET 1: 1200 SUMMIT AVE STREET 2: SUITE 414 CITY: FORT WORTH STATE: TX ZIP: 76102 FORMER COMPANY: FORMER CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC. DATE OF NAME CHANGE: 20080611 FORMER COMPANY: FORMER CONFORMED NAME: MB SOFTWARE CORP DATE OF NAME CHANGE: 19960805 FORMER COMPANY: FORMER CONFORMED NAME: INAV TRAVEL CORPORATION DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-02-07 0000714256 Sanara MedTech Inc. SMTI 0001766396 CGI Cellerate RX, LLC 1375 ENCLAVE BOULEVARD HOUSTON TX 77077 0 0 1 0 0001766398 Catalyst Rochal, LLC 1375 ENCLAVE BOULEVARD HOUSTON TX 77077 0 0 1 0 0001766399 Gurasich Bradley J. 7500 RIALTO BLVD., BUILDING II SUITE 220 AUSTIN TX 78735 0 0 1 0 Common Stock 2020-02-07 4 C 0 2273630 A 2273630 D Common Stock 2020-02-07 4 C 0 179101 9 A 2452731 D Series F Convertible Preferred Stock 2020-02-07 4 C 0 1136815 D Common Stock 2273630 0 D 5% Convertible Promissory Note 9 2020-02-07 4 C 0 1611911 D 2019-08-28 2021-03-01 Common Stock 179101 0 D The Series F Convertible Preferred Stock was convertible into Common Stock at any tme on a 2-for-1 basis and had no expiration date. When originally issued the conversion rate was 200-for-1, but on May 10, 2019, as a result of a 1-for-100 reverse stock split of the Common Stock, the conversion rate was automatically adjusted to a conversion rate of 2-for1 in accordance with the terms of the Series F Convertible Preferred Stock. Reflects shares of Common Stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Gurasich is a manager of Catalyst Rochal, LLC. By virture of these relationships, Mr. Gurasich, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the Common Stock. Mr. Gurasich and Catalyst Rochal, LLC disclaim beneficial ownership of any Common Stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein. The 5% Convertible Promissory Note in the principal amount of $1,500,000 was convertible into Common Stock at any time prior to maturity at an initial conversion price of $0.09 per share. As a result a 1-for-100 reverse stock split of the Common Stock on May 10, 2019, the conversion price was automatically adjusted to $9.00 per share in accordance with the terms of the Promissory Note. The terms of the Promissory Note also provided for the right of conversion of any accrued and unpaid interest. The amount of $111,911 in accrued interest was also converted into 12,434 shares of Common Stock at $9.00 per share. CGI CELLERATE RX, LLC, by /s/ Ron Nixon and /s/ Brad Gurasich 2020-02-11 CATALYST ROCHAL, LLC, by /s/ Ron Nixon and /s/ Brad Gurasich 2020-02-11 /s/ Brad Gurasich 2020-02-11